Many important strategies to reduce the spread of pandemic influenza need public participation. To assess public receptivity to such strategies, Steel-Fisher, et al. (2012) compared adoption of preventive behaviours in response to the 2009 H1N1 influenza pandemic among the public in five countries and examined whether certain non-pharmaceutical behaviours (such as handwashing) were deterrents to vaccination. The researchers also assessed public support for related public health recommendations.
Steel-Fisher, et al. (2012) used data from simultaneous telephone polls (mobile telephone and landline) in Argentina, Japan, Mexico, the UK and the U.S. In each country, interviews were conducted in a nationally representative sample of adults who were selected by the use of random digit dial techniques. The questionnaire asked people whether or not they had adopted each of various preventive behaviours (non-pharmaceuticalsuch as personal protective and social distancing behavioror vaccinations) to protect themselves or their family from H1N1 at any point during the pandemic.
Nine hundred people were surveyed in each country (except in the U.S. where 911 people were contacted). There were wide differences in the adoption of preventive behaviours between countries, although certain personal protective behaviors (e.g., handwashing) were more commonly adopted than social distancing behaviours (e.g., avoiding places where many people gather) across countries (89 percent versus 69 percent). These non-pharmaceutical behaviours did not reduce the likelihood of getting vaccinated in any country. There was also support across all countries for government recommendations related to school closure, avoiding places where many people gather, and wearing masks in public.
The researchers say their survey results show there is a need for country-specific approaches in pandemic policy planning that use both non-pharmaceutical approaches and vaccination.
Reference: Steel Fisher GK, et al. Public response to the 2009 influenza A H1N1 pandemic: a polling study in five countries. The Lancet Infectious Diseases. Early online publication Oct. 5, 2012.
Source: The Lancet Infectious Diseases
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.
The Neglected Tropical Diseases You’ve Never Heard Of
February 27th 2024The 20 conditions, known as neglected tropical diseases (NTDs), are estimated to affect more than 1 billion people, yet many individuals have never heard of them. Heather Saunders, MPH, RN, CIC, discusses 5 of them and what is being done to prevent their spread.